2 weeks Ago By Defense World Staff
Hims & Hers Health, Inc. ( NYSE:HIMS – Get Free Report ) was the recipient of a large drop in short interest in September. As of September 15th, there was short interest totalling 26,540,000 shares, a drop of 5.
3% from the August 31st total of 28,040,000 shares. Based on an average trading volume of 8,750,000 shares, the short-interest ratio is currently 3.0 days.
Currently, 16.2% of the company’s shares are sold short. Hims & Hers Health Trading Up 3.
7 % Shares of HIMS stock traded up $0.66 on Monday, reaching $18.43.
7,011,084 shares of the company’s stock were exchanged, compared to its average volume of 7,689,988. The company’s fifty day simple moving average is $16.89 and its 200 day simple moving average is $17.
22. The stock has a market capitalization of $3.96 billion, a PE ratio of -1,842.
50 and a beta of 1.05. Hims & Hers Health has a 52 week low of $5.
65 and a 52 week high of $25.74. Hims & Hers Health ( NYSE:HIMS – Get Free Report ) last posted its quarterly earnings data on Monday, August 5th.
The company reported $0.06 EPS for the quarter, topping the consensus estimate of $0.04 by $0.
02. Hims & Hers Health had a net margin of 1.70% and a return on equity of 5.
25%. The firm had revenue of $315.65 million during the quarter, compared to analyst estimates of $302.
43 million. During the same quarter in the previous year, the business posted ($0.03) EPS.
Hims & Hers Health’s revenue was up 51.8% on a year-over-year basis. As a group, sell-side analysts predict that Hims & Hers Health will post 0.
22 earnings per share for the current fiscal year. Analyst Upgrades and Downgrades View Our Latest Report on HIMS Insider Transactions at Hims & Hers Health In other news, insider Soleil Boughton sold 2,335 shares of the company’s stock in a transaction that occurred on Tuesday, July 9th. The stock was sold at an average price of $20.
28, for a total transaction of $47,353.80. Following the transaction, the insider now directly owns 169,144 shares of the company’s stock, valued at $3,430,240.
32. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website . In related news, insider Soleil Boughton sold 2,335 shares of the stock in a transaction on Tuesday, July 9th.
The stock was sold at an average price of $20.28, for a total value of $47,353.80.
Following the completion of the sale, the insider now directly owns 169,144 shares of the company’s stock, valued at approximately $3,430,240.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link .
Also, insider Michael Chi sold 2,054 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $22.00, for a total transaction of $45,188.
00. Following the completion of the sale, the insider now owns 185,326 shares of the company’s stock, valued at approximately $4,077,172. The disclosure for this sale can be found here .
In the last ninety days, insiders sold 731,473 shares of company stock valued at $12,671,277. Corporate insiders own 17.71% of the company’s stock.
Institutional Trading of Hims & Hers Health Several large investors have recently added to or reduced their stakes in the company. Nisa Investment Advisors LLC boosted its holdings in Hims & Hers Health by 679.2% in the second quarter.
Nisa Investment Advisors LLC now owns 1,839 shares of the company’s stock valued at $37,000 after purchasing an additional 1,603 shares during the last quarter. Quest Partners LLC raised its position in Hims & Hers Health by 5,944.1% during the second quarter.
Quest Partners LLC now owns 3,566 shares of the company’s stock valued at $72,000 after acquiring an additional 3,507 shares in the last quarter. Van ECK Associates Corp acquired a new position in Hims & Hers Health in the second quarter valued at approximately $111,000. Amalgamated Bank increased its holdings in shares of Hims & Hers Health by 55.
9% during the 2nd quarter. Amalgamated Bank now owns 6,566 shares of the company’s stock valued at $133,000 after purchasing an additional 2,354 shares in the last quarter. Finally, Daiwa Securities Group Inc.
purchased a new position in shares of Hims & Hers Health during the 2nd quarter valued at approximately $142,000. Hedge funds and other institutional investors own 63.52% of the company’s stock.
About Hims & Hers Health ( Get Free Report ) Hims & Hers Health, Inc operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. Featured Stories Five stocks we like better than Hims & Hers Health 10 Best Airline Stocks to Buy TJX Stock: A Buying Opportunity Before the Holiday Rush Where Do I Find 52-Week Highs and Lows? Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge How to invest in marijuana stocks in 7 steps Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth Receive News & Ratings for Hims & Hers Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hims & Hers Health and related companies with MarketBeat.
com's FREE daily email newsletter ..
